Wilmington Savings Fund Society’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$134K Hold
1,182
﹤0.01% 933
2025
Q1
$124K Sell
1,182
-618
-34% -$65K ﹤0.01% 940
2024
Q4
$193K Hold
1,800
﹤0.01% 841
2024
Q3
$180K Buy
+1,800
New +$180K ﹤0.01% 854